Web only references

  1. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602
  2. Carrel A, Guthrie CC. The transplantation of veins and organs. Am Med 1905;10:1101-1102
  3. Mann FC, Priestley JT, Markowitz J, et al. Transplantation of the intact mammalian heart. Arch Surg 1933;26:219-224
  4. Lower RR, Shumway NE. Studies in orthotopic homotransplantations of the canine heart. Surg Forum 1960;11:18-19
  5. Demikhov VP. Experimental transplantation of vital organs. New York, Consultants Bureau 1962
  6. Barnard CN. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41:1271-1274
  7. Ad Hoc committee report of the Harvard Medical School to examine the definition of brain death. A definition of irreversible coma. JAMA 1968;205:85-88
  8. Hosenpud JD, Cobanoglu A, Norman DJ, Starr A (Eds): Cardiac Transplantation. Springer New York 1990
  9. Thompson ME (Ed). Cardiac transplantation. Davis, Philadelphia 1990
  10. Williams BAH, Grady KL, Sandiford-Guttenbeil DM. Organ transplantation: A manual for nurses. Springer New York 1991
  11. Rose ML, Yacoub MH. Immunology of Heart and Lung Transplantation. Arnold London 1993
  12. Smith JA, McCarthy PM, Sarris GE, Stinson EB, Reitz BA. The Stanford Manual of Cardiopulmonary Transplantation. Futura Publishing Company New York 1996
  13. Rose EA, Stevenson LW (eds). Management of end-stage heart disease. Lippincott-Raven, Philadelphia 1998
  14. Scheld HH, Deng MC, Hammel D, Schmid C. Leitfaden Herztransplantation-Interdisziplinaere Betreuung vor, waehrend und nach Herztransplantation (2nd ed). Steinkopff, Darmstadt 2001
  15. Shelton W, Balint J (eds). The Ethics of Organ Transplantation. JAI Elsevier Science New York 2001
  16. Swedberg K for Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435.
  17. Athanasuleas CL, Stanley AW Jr, Buckberg GD, Dor V, DiDonato M, Blackstone EH. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. J Am Coll Cardiol 2001;37:1199-209
  18. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. Thorac Cardiovasc Surg 1998;115:381-6.
  19. McCarthy PM, Starling RC, Young JB, Smedira NG, Goormastic M, Buda T. Left ventricular reduction surgery with mitral valve repair. J Heart Lung Transplant 2000;19:S64-7.
  20. Deng MC, Loebe M, El-Banayosi A, Gronda E, Jansen PGM, Vigano M, Wieselthaler G, Reichart B, Vitali E, Pavie A, Mesana T, Loisance D, Wheeldon DR, Portner PM. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001 103: 231 – 237.
  21. Hetzer R, Muller JH, Weng YG, Loebe M, Wallukat G. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy. J Thorac Cardiovasc Surg 2000;120:843-55.
  22. Helman DN, Maybaum SW, Morales DL, Williams MR, Beniaminovitz A, Edwards NM, Mancini DM, Oz MC. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable? Ann Thorac Surg 2000;70:1255-8.
  23. Katsumata T, Westaby S. Implantable axial flow impeller pumps. J Circ Support. 1998;1:13-19.
  24. Wieselthaler GM, Schima H, Hiesmayr M et al. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation. 2000;101:256-259.
  25. Westaby S. Non-transplant surgery for heart failure. Heart 2000;83:603-10
  26. Gollob MH, Seger JJ. Current status of the implantable cardioverter-defibrillator. Chest 2001;119:1210-21
  27. Laffel Gl, Barnett A, Finkelstein S, Kaye MP. The Relationship between Experience and Outcome in Heart Transplantation. N. Engl J Med 1992;327:1220-1225.
  28. Reemtsma K, Berland G, Merrill J, Arons R, Evans C, Drusin R, Smith CR, Rose EA. Evaluation of surgical procedures. Changing patterns of patient selection and costs in heart transplantation. J Thorac Cardiovasc Surg 1992;104: 1308-11
  29. Aziz T, Burgess M, Rahman A, Campbell C, Deiraniya A, Yonan N. Early and long-term results of heart transplantation after previous cardiac surgery. Eur J Cardiothorac Surg 2000;17:349-54
  30. Carrel T, Neth J, Mohacsi P, Gallino A, Turina MI. Perioperative risk and long-term results of heart transplantation after previous cardiac operations. Ann Thorac Surg 1997;63:1133-7.
  31. Wegner JA, DiNardo JA, Arabia FA, Copeland JG. Blood loss and transfusion requirements in patients implanted with a mechanical circulatory support device undergoing cardiac transplantation. J Heart Lung Transplant 2000;19:504-6
  32. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival following left ventricular assist device insertion. (submitted)
  33. Taylor DO, Farhoud HH, Kfoury G, Pham SM, Pigula FA, Kormos RL, Renlund DG. Cardiac transplantation in survivors of lymphoma: a multi-institutional survey. Transplantation 2000;69:2112-5.
  34. Hulsmann M, Stefenelli T, Berger R, Sturm B, Parkner A, Zuckermann A, Woloszczuk W, Pacher R. Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation. J Heart Lung Transplant 2000;19:939-45
  35. Thompson JS, Thacker LR 2nd, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation 2000;69: 2178-86.
  36. John R, Rajasinghe H, Chen JM, Weinberg AD, Sinha P, Itescu S, Lietz K, Mancini D, Oz MC, Smith CR, Rose EA, Edwards NM. Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients. Ann Surg 2000;232:302-11.
  37. Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, Eisen HJ, Kirklin JK, Bourge RC. Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy. J Heart Lung Transplant 2001;20:449-56
  38. Potapov EV, Loebe M, Hübler M, Musci M, Hummel M, Weng Y, Hetzer R. Medium-term results of heart transplantation using donors over 63 years of age. Transplantation 1999;68:1834-8
  39. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. J Heart Lung Transplant 1999;18:611-26.
  40. Kono T, Nishina T, Morita H, Hirota Y, Kawamura K, Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 1999;84:578-82.
  41. Laks H, Marelli D. The alternate recipient list for heart transplantation: a model for expansion of the donor pool. Advances in Cardiac Surgery. 1999;11:233-44.
  42. Deng MC, Hauff H, Itescu S, Taranto S, Scully B, Brown Jr. RS, Smits JMA, Edwards NM. The Seropositive Donor Heart [abstract]. J Heart Lung Transplant (in press).
  43. MacLean A, Dunning J. The retrieval of thoracic organs: donor assessment and management. Br Med Bull 1997;53:829-43
  44. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43:852-4
  45. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation. 1990;49:311-6
  46. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59:58-62
  47. Snell GI, Griffiths A, Macfarlane L, Gabbay E, Shiraishi T, Esmore DS, Williams TJ. Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant 2000;19:401-7
  48. Bumgardner GL, Orosz CG. Transplantation and cytokines. Semin Liver Dis 1999;19:189-204
  49. Orosz CG, VanBuskirk AM. Immune mechanisms of acute rejection. Transplant Proc 1998;30:859-61
  50. Hunt SA. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. Cardiol Rev 2000;8:180-4
  51. Straatman LP, Coles JG. Pediatric utilization of rapamycin for severe cardiac allograft rejection. Transplantation 2000;70:541-3
  52. Caves P, Stinson E, Billingham M, Rider A, Shumway N. Diagnosis of human cardiac rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg 1973:66:461-466
  53. Winters GL. The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection. Curr Opin Cardiol 1997;12:146-52
  54. Rubin RH. Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant 2000;19:731-5
  55. Knirsch CA, Jakob K, Schoonmaker D, Kiehlbauch JA, Wong SJ, Della-Latta P, Whittier S, Layton M, Scully B. An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control. Am J Med 2000;108:290-5
  56. Munoz P, Munoz RM, Palomo J, Rodriguez-Creixems M, Munoz R, Bouza E. Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. Medicine 1997;76:415-22
  57. Aguado JM, Herrero JA, Gavalda J, Torre-Cisneros J, Blanes M, Rufi G, Moreno A, Gurgui M, Hayek M, Lumbreras C, Cantarell C. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 1997;63:1278-86
  58. Gallino A, Maggiorini M, Kiowski W, Martin X, Wunderli W, Schneider J, Turina M, Follath F. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996;15:389-93
  59. Utili R, Zampino R, De Vivo F, Maiello C, Andreana A, Mormone G, Marra C, Tripodi MF, Sarnataro G, Cione P, Cuccurullo S, Cotrufo M. Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. Clin Transplant 2000;14:282-6
  60. Schulman LL, Htun T, Staniloae C, McGregor CC, Austin JH. Pulmonary nodules and masses after lung and heart-lung transplantation. J Thorac Imaging 2000;15:173-9
  61. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000;70:112-6
  62. Deng MC, Plenz G, Erren M, Wilhelm MJ, Moennig G, Rothenburger M, Baba HA. Transplant Vasculopathy: a Model for Coronary Artery Disease? Herz 2000;25:95-99
  63. Shirali GS, Ni J, Chinnock RE, Johnston JK, Rosenthal GL, Bowles NE, Towbin JA. Association of Viral Genome with Graft Loss in Children after Cardiac Transplantation. N Engl J Med 2001;344:1498-1503
  64. Behrendt D, Ganz P, Fang JC. Cardiac allograft vasculopathy. Curr Opin Cardiol 2000;15:422-9
  65. Schroeder JS, Gao SZ, Aldermann EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederhold V, Stinson EB. A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients. N Engl J Med 1993;328:164-170
  66. Wenke K, Meiser B, Thiery J, Nagel D, Scheidt Wv, Steinbeck G, Seidel D, Reichart B. Simvastatin reduces graft vessel disease and mortality after heart transplantation: A four-year ramdomized trial. Circulation 1997;96:1398-1402
  67. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993;7:431-445
  68. Zilz ND, Olson LJ, McGregor CG. Treatment of post-transplant lymphoproliferative disorder with monoclonal cd20 antibody (rituximab) after heart transplantation. J Heart Lung Transplant 2001;20:770-772
  69. Hauptman PJ, Kartashov AI, Couper GS, Mudge GH Jr., Aranki SF, Cohn LH, Adams DH. Changing patterns in donor and recipient risk: a 10-year evolution in one heart transplant center. J Heart Lung Transplant 1995;14: 654-8
  70. Rodeheffer RJ, Naftel DC, Stevenson LW, Porter CB, Young JB, Miller LW, Kenzora JL, Haas GJ, Kirklin JK, Bourge RC. Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group. Circulation 1996;94: 2883-9
  71. Edwards NM, Rajasinghe HA, John R, Chen JM, Itescu S, Mancini DM. Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University. Clin Transpl 1999:249-61
  72. Sherlaw-Johnson C, Lovegrove J, Treasure T, Gallivan S. Likely variations in perioperative mortality associated with cardiac surgery: when does high mortality reflect bad practice? Heart 2000; 84: 79- 82.
  73. Whellan DJ, Tudor G, Denofrio D, AbramsJD, Loh E. Heart transplant center practice patterns affect access to donors and survival of patients classified as status 1 by the United Network of Organ Sharing. Am Heart J 2000;140: 443-50
  74. Smits JMA , De Meester J, Deng MC, Scheld HH, Hummel M, Schoendube F, Haverich A, Vanhaecke J, van Houwelingen HC on behalf of the COCPIT study group and the Eurotransplant Heart Transplant Programs. Mortality rates after heart transplantation. How to compare center-specific outcome data? (submitted)
  75. Stevenson LW. Selection and management of patients for cardiac transplantation. Curr Opin Cardiol 1993;8:411-8
  76. Hunt SA. A fair way of donating hearts for transplantation. BMJ 2000;321:326
  77. Treasure T, Murday A. Time for a controlled trial? BMJ 2000;321:545
  78. St. John Kolar D. Cardiovascular News: Heart transplantation survival rate best in high-risk group. Circulation 2000;102:e9024
  79. Deng MC, Smits JMA, DeMeester J, Hummel M, Schoendube F, Scheld HH. Heart Transplantation is indicated only in the most severely ill patient: Perspectives from the German Heart Transplant Experience. Curr Opin Cardiol 2001; 16:97-104
  80. Deng MC, DeMeester J, Scheld HH. Development of cardiac transplant policy in Germany. Thorac Cardiovasc Surgeon 2000;48:183-185.
  81. Etzion S, Battler A, Barbash IM, Cagnano E, Zarin P, Granot Y, Kedes LH, Kloner RA, Leor J. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001;33:1321-30
  82. Yokomuro H, Li RK, Mickle DA, Weisel RD, Verma S, Yau TM. Transplantation of cryopreserved cardiomyocytes. J Thorac Cardiovasc Surg 2001;121:98-107
  83. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000;102(19 Suppl 3):III56-61
  84. El Oakley RM, Ooi OC, Bongso A, Yacoub MH. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 2001;71:1724-33
  85. Yoo KJ, Li RK, Weisel RD, Mickle DA, Li G, Yau TM. Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg 2000;70:859-65
  86. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 2000;9:359-68
  87. Hammer C. Xenotransplantation: perspectives and limits. Blood Purif 2001;19:322-8
  88. Mihaylov D, Verkerke GJ, Rakhorst G. Mechanical circulatory support systems--a review. Technol Health Care 2000;8:251-66
  89. Young JB. Healing the heart with ventricular assist device therapy: mechanisms of cardiac recovery. Ann Thorac Surg 2001;71(3 Suppl):S210-9
  90. Mehta SM, Pae WE Jr, Rosenberg G, Snyder AJ, Weiss WJ, Lewis JP, Frank DJ, Thompson JJ, Pierce WS. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg 2001;71(3 Suppl):S156-61